KKR buys Japanese drugmaker Bushu Pharmaceuticals from BPEA EQT

KKR buys Japanese drugmaker Bushu Pharmaceuticals from BPEA EQT

Photo by Hal Gatewood on Unsplash

US private equity heavyweight KKR has acquired all shares in Japan-based drug contract manufacturer Bushu Pharmaceuticals from pan-Asian private equity firm Baring Private Equity Asia, which is owned by EQT AB.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter